Matthew Angel is President and CEO of Eterna Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Jan 23 | ERNA Eterna Therapeutics | Stock Option Common Stock, par value $0.005 per share | Grant | Acquire A | No | No | 4.84 | 132,003 | 638.89 k | 132,003 |